Abstract:Gemcitabine (Gem), an analogue of deoxycytidine, has potent antitumor activities against various solid tumors and is an excellent radiosensitizer as well. However, Gem has a very short half-life, making it difficult to achieve the long-term synergies between chemotherapy and radiotherapy. Herein, we developed a long-acting Gem delivery system using a palmityl modified Gem derivative (GemC16) as the drug and an injectable and thermosensitive hydrogel as the vehicle, and then combined with multiple radiation therapy for the synergistic treatment of tumors. The thermosensitive hydrogel that exhibited a temperature-responsive sol–gel transition was composed of two poly(D,L-lactic acid-co-glycolic acid)-b-poly(ethylene glycol)-b-poly(D,L-lactic acid-co-glycolic acid) (PLGA-PEG-PLGA) triblock copolymers with different PLGA/PEG ratios. Such a physical hydrogel formed an internal structure of percolated micelle network, in which the polymeric micelles played a reservoir role in effectively solubilizing lipophilic GemC16 in water. In vitro tests manifested that the entrapped GemC16 was, in the form of micelles and micellar aggregates, released out of the hydrogel depot in a sustained pattern for over one month. In vitro cellular assays demonstrated that GemC16 mediated by the polymeric micelles was rapidly internalized to tumor cells via endocytosis. After a single peritumoral administration of the hydrogel system combined with local multiple X ray exposures, the sustained release of GemC16 exerted a long-acting chemotherapy effect and afforded a durable radiosensitization, thereby synergistically enhancing chemoradiotherapy efficacy, inhibiting metastasis and ameliorating complications.

Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma.

Peritumoral Microgel Reservoir for Long-Term Light-Controlled Triple-Synergistic Treatment of Osteosarcoma with Single Ultra-Low Dose.

Localized Co-delivery of Doxorubicin, Cisplatin, and Methotrexate by Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment

Injectable Hydrogel-Microsphere Construct with Sequential Degradation for Locally Synergistic Chemotherapy

Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment

Anticancer and bone-enhanced nano-hydroxyapatite/gelatin/polylactic acid fibrous membrane with dual drug delivery and sequential release for osteosarcoma

Long-Circulating and Targeted Liposomes Co-loading Cisplatin and Mifamurtide: Formulation and Delivery in Osteosarcoma Cells

A conductive gelatin methacrylamide hydrogel for synergistic therapy of osteosarcoma and potential bone regeneration

Adriamycin-loaded Gelatin Microspheres in the Treatment of Bone Tumors

PLK1shRNA and Doxorubicin Co-Loaded Thermosensitive PLGA-PEG-PLGA Hydrogels for Osteosarcoma Treatment

Nanocomposite multifunctional hydrogel for suppressing osteosarcoma recurrence and enhancing bone regeneration

Ph-Responsive Hydrogel with Gambogic Acid and Calcium Nanowires for Promoting Mitochondrial Apoptosis in Osteosarcoma

Supramolecular hydrogel-loaded Prussian blue nanoparticles with photothermal and ROS scavenging ability for tumor postoperative treatments

Enhancing Osteosarcoma Killing and CT Imaging Using Ultrahigh Drug Loading and NIR-Responsive Bismuth Sulfide@Mesoporous Silica Nanoparticles

Injectable rhein-assisted crosslinked hydrogel for efficient local osteosarcoma chemotherapy

MXene-Based Hydrogels Endow Polyetheretherketone with Effective Osteogenicity and Combined Treatment of Osteosarcoma and Bacterial Infection

Sustained release of lipophilic gemcitabine from an injectable polymeric hydrogel for synergistically enhancing tumor chemoradiotherapy

Fabrication of Micro-Nano Bioactive Glass Scaffold Incorporated with Siglec-15 for Bone Repair and Postoperative Treatment of Osteosarcoma

A new therapeutic combination for osteosarcoma: Gemcitabine and Clofazimine co-loaded liposomal formulation

Bioinspired adhesive nanofibrous hydrogel promotes immune infiltration through effective immunochemotherapy for osteosarcoma treatment

Targeted osteosarcoma chemotherapy using RGD peptide-installed doxorubicin-loaded biodegradable polymeric micelle